Health Care: Drugs

Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)

$1.47 0.14 | 10.53%
07/30/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 5.73M 7.96M 3.75M 5.00M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 5.73M 7.96M 3.75M 5.00M
Selling, General, and Administrative Expenses 23.11M 10.84M 9.18M 8.30M
Research & Development 27.66M 28.89M 29.18M 22.56M
Operating Income before D & A (EBITDA) -45.04M -31.77M -34.61M -25.87M
Depreciation & Amortization 396.00K 641.00K 431.00K 112.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 3.76M 92.00K -7.49M 6.02M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -41.68M -32.32M -42.53M -19.95M
Interest Expense 1.72M 2.92M 1.86M 300.00K
Pre-Tax Income -43.40M -35.24M -44.38M -20.25M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -43.00M -34.60M -43.95M -20.14M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -43.00M -34.60M -43.95M -20.14M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -43.00M -34.60M -43.95M -20.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-43.00M -34.60M -43.95M -20.14M
Preferred Dividends
Net Income Available To Common -43.00M -34.60M -43.95M -20.14M
Basic EPS from Continuing Ops. -0.72 -0.66 -0.91 -0.43
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.72 -0.66 -0.91 -0.43
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.72 -0.66 -0.91 -0.43
Basic Normalized Net Income/Share -0.72 -0.66 -0.91 -0.43
EPS fr Continuing Ops. -0.72 -0.66 -0.91 -0.43
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.72 -0.66 -0.91 -0.43
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.04 0.00 0.00 0.00
EPS, Total -0.76 -0.66 -0.91 -0.43
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.72 -0.66 -0.91 -0.43
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SNSS

Latest SNSS Headlines from TheStreet

More Financial News for SNSS

Press Releases for SNSS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter